IBIO
iBio, Inc. · AMEX
- Sector Health Technology
- Industry Pharmaceuticals: Other
- Website ibioinc.com
- Employees(FY) 26
- ISIN US4510337086
Performance
+5.32%
1W
+1.54%
1M
+57.14%
3M
-63.02%
6M
+44.53%
YTD
-89.71%
1Y
Profile
iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel. The company is also developing vaccine candidates, including IBIO-101, an antibody to reduce tumor growth; Endostatin E4 peptide for use in chemotherapy and immunotherapy; Trop-2 for the treatment Trop-2 positive cancers; MUC16, a tumor-associated epitope; anti-EGFRvIII antibody to treat glioblastoma and other cancers; CCR8 protein candidate for treatment of various cancers; PD-1 agonist for the treatment of rheumatoid arthritis and other inflammatory diseases; and IBIO-400 for the treatment of classical swine fever. iBio, Inc. has agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; and a research collaboration with the National Institute of Allergy and Infectious Diseases to investigate the potential of the company's AI-driven epitope steering platform for the development of a vaccine for Lassa fever. The company was incorporated in 2008 and is headquartered in Bryan, Texas.
Technical Analysis of IBIO 2024-05-10
Overview:
In analyzing the technical indicators for IBIO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-13 04:05
- 2024-04-05 02:35
- 2024-03-26 19:00
- 2024-03-26 07:35
iBio Announces $15.0 Million Private Placement(Globenewswire)
- 2024-03-24 03:54
12 Best Biotech Penny Stocks to Invest In(Yahoo Finance)
- 2024-02-25 18:45
- 2024-01-15 19:15
- 2023-12-25 18:15
iBio Amends and Extends Maturity of Credit Agreement(Yahoo Finance)
- 2023-12-04 19:00
iBio, Inc. Announces Pricing of $4.5 Million Public Offering(Yahoo Finance)
- 2023-11-27 04:20
iBio Announces Reverse Stock Split(Yahoo Finance)
- 2023-10-31 20:24
- 2023-10-09 20:00
- 2023-10-01 18:45
iBio Explains Recent Filing of Registration Statement(Yahoo Finance)
- 2023-09-27 04:19
iBio Announces Filing of 2023 Annual Report on SEC Form 10-K(Yahoo Finance)
- 2023-09-21 04:05
iBio Announces Amendment to Credit Agreement with Woodforest(Yahoo Finance)
- 2023-08-14 04:15
- 2023-06-26 20:00
- 2023-06-19 20:25
3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever(Yahoo Finance)
- 2023-06-12 04:15
- 2023-06-05 20:00
- 2023-05-09 04:30
- 2023-04-04 04:05
- 2023-03-30 20:10
- 2023-02-16 03:48
- 2023-01-04 19:00
- 2022-12-09 03:05
- 2022-12-06 10:27
- 2022-12-06 03:01
iBio Announces Proposed Underwritten Public Offering(Yahoo Finance)
- 2022-12-05 19:00
- 2022-12-04 19:00
Page 1 of 4
previousnext